Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...